ArticleFrontiers in pharmacology2019

Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate.

Madelé van Dyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.